Status:
UNKNOWN
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
Lead Sponsor:
Assiut University
Conditions:
SLE (Systemic Lupus)
Eligibility:
All Genders
18-75 years
Brief Summary
* Estimation of the serum ATX level in SLE patients in comparison to healthy subjects. * Evaluation of the relation of serum ATX level with disease activity and different clinical manifestation in SLE...
Detailed Description
Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune inflammatory disease with unknown etiology . However, several genetic, immunological and environmental factors play a role in the...
Eligibility Criteria
Inclusion
- Patients who will be diagnosed as SLE according to the 2012 systemic lupus international collaborating clinics (SLICC) criteria .
- SLE Patients older than 18 years old.
Exclusion
- SLE Patients younger than 18 years old.
- Patients with other rheumatic diseases or overlap syndromes.
- Patients with malignancy.
- Patients with chronic hepatitis C.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06063668
Start Date
October 1 2023
End Date
October 1 2025
Last Update
October 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.